Fig. 2From: New pre-treatment eosinophil-related ratios as prognostic biomarkers for survival outcomes in endometrial cancerOverall survival of patients with endometrial cancer (n = 163) according to the Eosinophil*Neutrophil-to-Lymphocytes Ratio (ENLR, cut-off ≥ 0.5), p = 0.010Back to article page